Back to search

Article

RFX6 at locus 6q22 confers metastasis and drug resistance in prostate cancer

2024-01-09

Abstract excerpt

Genetic and nonmutational epigenetic alterations are cancer hallmark characteristics. However, the role of inherited cancer predisposition alleles in co-opting lineage factor epigenetic reprogramming and contributing to tumor progression remains elusive. Here the FinnGen cohort phenome-wide analysis, along with recent multiple genome-wide association studies, has consistently identified the rs339331-RFX6/6q22 locu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db1456a0-1d49-5a75-80f0-661f41991779
DOI
10.1101/2024.01.08.574758
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RFX6 at locus 6q22 confers metastasis and drug resistance in prostate cancerDOI 10.1101/2024.01.08.574758
Select a neighboring publication to make it the new centre.